Skip to main content

Table 4 Risk ratios and 95 % confidence intervals for the association between educational level and having outcome measures of rheumatoid arthritis decrease over the median, or achieve remission

From: Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register

Visits

University/college degree

Outcome values decrease over the median or achieve remission

No

Yes

Risk ratio crude (95 % CI)

Risk ratio* (95 % CI)

DAS28 low disease activity

 3 months

No

960 (76.4)

297 (23.6)

1.0 ref.

1.0 ref.

Yes

789 (74.8)

266 (25.2)

1.05 (0.95 to 1.16)

1.00 (0.91 to 1.11)

 6 months

No

737 (78.2)

206 (21.8)

1.0 ref.

1.0 ref.

Yes

801 (77.3)

235 (22.7)

1.02 (0.93 to 1.13)

0.98 (0.88 to 1.09)

 1 year

No

822 (78.2)

229 (21.8)

1.0 ref.

1.0 ref.

Yes

1160 (75.4)

379 (24.6)

1.07 (0.99 to 1.14)

1.04 (0.97 to 1.13)

DAS28 good response

 3 months

No

1073 (75.9)

340 (24.1)

1.0 ref.

1.0 ref.

Yes

642 (75.3)

211 (24.7)

1.02 (0.91 to 1.16)

0.98 (0.86 to 1.11)

 6 months

No

829 (78.1)

233 (21.9)

1.0 ref.

1.0 ref.

Yes

682 (77.8)

195 (22.2)

1.01 (0.90 to 1.14)

0.96 (0.85 to 1.08)

 1 year

No

964 (78.5)

264 (21.5)

1.0 ref.

1.0 ref.

Yes

960 (75.0)

320 (25.0)

1.10 (1.01 to 1.20)

1.07 (0.98 to 1.17)

DAS28 remission

 3 months

No

1214 (76.6)

371 (23.4)

1.0 ref.

1.0 ref.

Yes

535 (73.6)

192 (26.4)

1.11 (0.97 to 1.28)

1.11 (0.97 to 1.28)

 6 months

No

962 (78.3)

267 (21.7)

1.0 ref.

1.0 ref.

Yes

576 (76.8)

174 (23.2)

1.05 (0.92 to 1.20)

1.00 (0.87 to 1.15)

 1 year

No

1141 (78.2)

318 (21.8)

1.0 ref.

1.0 ref.

Yes

841 (74.4)

290 (25.6)

1.12 (1.02 to 1.24)

1.11 (1.00 to 1.23)

VAS-pain decrease over the median

 3 months

No

831 (75.3)

273 (24.7)

1.0 ref.

1.0 ref.

Yes

882 (76.8)

266 (23.2)

0.96 (0.87 to 1.06)

1.06 (0.97 to 1.16)

 6 months

No

750 (77.9)

213 (22.1)

1.0 ref.

1.0 ref.

Yes

763 (78.3)

212 (21.7)

0.99 (0.89 to 1.10)

1.08 (0.98 to 1.19)

 1 year

No

938 (75.9)

298 (24.1)

1.0 ref.

1.0 ref.

Yes

991 (77.5)

288 (22.5)

0.96 (0.87 to 1.05)

1.05 (0.96 to 1.14)

VAS-pain remission

 3 months

No

1055 (79.0)

281 (21.0)

1.0 ref.

1.0 ref.

Yes

710 (71.6)

282 (28.4)

1.25 (1.13 to 1.38)

1.13 (1.02 to 1.26)

 6 months

No

892 (79.7)

227 (20.3)

1.0 ref.

1.0 ref.

Yes

663 (75.4)

216 (24.6)

1.14 (1.02 to 1.28)

1.08 (0.96 to 1.22)

 1 year

No

1115 (79.0)

297 (21.0)

1.0 ref.

1.0 ref.

Yes

890 (73.6)

319 (26.4)

1.17 (1.07 to 1.28)

1.10 (1.00 to 1.21)

HAQ decrease over the median

 3 months

No

796 (76.9)

239 (23.1)

1.0 ref.

1.0 ref.

Yes

842 (74.8)

283 (25.2)

1.05 (0.96 to 1.16)

1.11 (1.02 to 1.21)

 6 months

No

706 (79.0)

188 (21.0)

1.0 ref.

1.0 ref.

Yes

734 (76.6)

224 (23.4)

1.07 (0.96 to 1.18)

1.10 (0.99 to 1.21)

 1 year

No

872 (78.6)

237 (21.4)

1.0 ref.

1.0 ref.

Yes

949 (74.6)

323 (25.4)

1.11 (1.02 to 1.20)

1.15 (1.06 to 1.25)

  1. Risk ratio crude: poisson regression estimates without adjustment. Risk ratio*: poisson regression estimates adjusted for age at the diagnosis, gender, alcohol assumption, pack-years of smoking, body mass index, and baseline outcome values. DAS28 disease activity in 29 joints, VAS visual analog scale, HAQ health assessment questionnaire